Planmed launches improved Planmed Verity® CBCT Scanner
Planmed is proud to present the improved Planmed Verity® CBCT scanner – a unique 3D imaging solution for orthopedic as well as head and neck imaging. The scanner now offers enhanced image quality, new options for head and neck imaging, Planmeca Ultra Low Dose™ imaging protocol for lower patient doses, and Planmeca CALM™ algorithm for motion artefact correction.
New options for head and neck imaging with exceptional image quality
Image quality of the adaptable and mobile Planmed Verity® has been enhanced to meet all imaging needs. The high-quality images of Planmed Verity visualize even the smallest bone structures with minimal interference. This exceptional image quality combined with new patient and volume positioning options makes it possible to acquire images of the head and neck region with greater precision than before. Planmed Verity covers ear, nose, and throat imaging as well as basic 3D dental imaging needs.
“We are pleased to further improve Planmed Verity and its maxillofacial and ENT imaging options. This is something our customers have requested, and we are happy to answer this need,” says Jan Moed, Managing Director of Planmed. “This unit is now more versatile than ever before. It is an easy-to-use and cost-efficient solution making it a great tool for any imaging center, clinic or hospital.”
New algorithm solves the challenge of movement artefacts
The groundbreaking Planmeca CALM™ motion artefact correction is now available for Planmed Verity. Planmeca CALM algorithm eliminates the need for retakes by cancelling the effects of patient movement, which makes it excellent for imaging more lively patients. This feature will not only save time for clinicians but also guard patients from unnecessary doses.
Lower patient doses with Planmeca Ultra Low Dose™ protocol
Also the innovative Planmeca Ultra Low Dose (ULD) imaging protocol is now available for the Planmed Verity scanner. Planmeca ULD combines clinical image quality with extremely low effective patient doses, enabling 3D imaging with a dose close to standard 2D imaging. The protocol allows reducing the Planmed Verity scanner’s already low effective patient doses by 50% without compromising diagnostic image quality. Also, the new volume positioning possibilities enable enhanced accuracy to the imaging area reducing the amount of radiation your patients are exposed to.
“New innovative features such as Planmeca CALM and Planmeca ULD are great examples of the fruits of our deep collaboration with our parent company Planmeca. I’m extremely excited to see the heights our unique Planmed Verity scanner can reach within the world of medical imaging,“ Moed concludes.
The new features are now available inside the European Union and other countries in the European Economic Area where CE mark applies.
For more information, please contact:
Product Portfolio and Business Development Director,
Tel. 00 358 20 779 5706
Planmed Oy and Planmeca Group
Planmed Oy develops, manufactures, and markets advanced imaging equipment and accessories for mammography and orthopedic imaging. Planmed's extensive mammography product range covers digital and analog units and digital breast tomosynthesis (DBT) systems, stereotactic biopsy devices, and breast positioning systems for early detection of breast cancer. For orthopedic 3D imaging Planmed offers low dose extremity CT imaging for quicker, easier and more accurate diagnosis at point-of-care. Planmed Oy is strongly committed to R&D and design and the company exports more than 98% of its production to over 70 countries worldwide. Planmed Oy was established in 1989 and the company’s headquarters are located in Helsinki, Finland. Planmed Oy is part of Planmeca Group. The Group's turnover in 2016 was MEUR 730, employing nearly 2,700 people worldwide.